Eastman Kodak Q3 2026 Earnings Conference Call - EASTMAN KODAK CO

Financial Performance:

• Consolidated revenue reached $276 million in Q3 2026, a 3% year-over-year (YoY) increase of $7 million.
• Gross profit increased 7% YoY to $73 million; gross margin expanded to 26% from 25% in the prior year quarter.
• Operational EBITDA rose 7% YoY to $31 million, up $2 million from Q3 2025; YTD operational EBITDA for the first nine months was $82 million.
• GAAP net income improved significantly by 62% YoY to $21 million, driven by lower interest expenses and reduced impairment charges.
• Free cash flow generation totaled $27 million for the quarter; YTD free cash flow showed marked improvement.
• Net cash position strengthened to $207 million as of September 30, 2026, an increase of $79 million from year-end 2025.
• Unrestricted cash balance increased to $317 million, while total debt was reduced by approximately $400 million over the past 12 months.

Guidance and Future Outlook:

• Management aims to deliver consistent cash generation and continue executing on a long-term plan to create shareholder value.
• Advanced Materials & Chemicals (AM&C) is identified as the primary growth engine, with the company continuing to invest in capacity and technology.
• The print business is targeted for selective growth in profitable regions, specifically the United States, while managing global headwinds.
• Long-term goal is to remain "the last manufacturer standing" in the print sector, with expectations for the imprinting systems business to make significant contributions.
• Management indicated continued investment in operational infrastructure, including automation to reduce reporting timelines by one week.

Business Segments and Product Lines:

• Advanced Materials & Chemicals (AM&C): Revenue surged 21% YoY to $99 million; now accounts for ~36% of total revenue and >50% of operational EBITDA. Highlights include film distribution growth, new saline product launch in Pharma, and battery coating capacity expansion.
• Commercial Print: Revenue declined 7% YoY to $165 million, attributed to raw material price/availability issues, digital substitution, European market pressures, and competitive pricing.
• Brand Licensing: Contributing to overall revenue growth alongside print and AM&C, though specific segment revenue figures were not isolated in the summary.
• Product Launches: Introduction of the Kodak Pharmaceutical Web Store; expansion of film offerings sold directly to distributors; increased focus on VistaVision format for major motion pictures.

Market and Competitive Landscape:

• Print business faces headwinds from digital substitution and an "uneven playing field" in Europe.
• Motion picture film remains the capture medium of choice for major features, including recent releases like Sense and Sensibility and Digger.
• The company is strategically focusing on high-margin, complex pharmaceutical products pending Class II manufacturing certification.
• AM&C growth demonstrates a successful turnaround, converting a long-term investment into a dominant profit contributor.

Risks and Challenges:

• Raw material cost volatility and availability issues negatively impacted print margins.
• Higher SG&A costs, primarily driven by increased equity compensation and changes in employee benefit accruals, offset some operational gains.
• Digital substitution continues to pressure the commercial print segment's volume.
• Forward-looking statements carry risks of deviation due to market conditions, currency fluctuations, and unspecified factors detailed in SEC filings.

Management Commentary and Tone:

• Tone was confident and positive, emphasizing strong execution of the long-term plan and operational improvements.
• Leadership highlighted the "smart revenue approach" and infrastructure investments as key drivers for margin expansion and liquidity improvement.
• Management expressed comfort with current debt levels and the company's ability to generate cash amidst a challenging market environment.
• CEO Jim Continenza reiterated the strategic intent to maintain print leadership while accelerating profitable growth in AM&C.

Analyst Questions and Answers:

• No formal Q&A session was held; the call concluded with a summary statement from the CEO.
• Investor Relations team is available for follow-up inquiries.

Other Key Points:

• Form 10-Q filed concurrently with the earnings release.
• Non-GAAP measures were reconciled in the accompanying financial release and website materials.
• Capital Management Scorecard metrics indicate liquidity has almost doubled compared to 2025.
• Pension income impact from the CRIP plan termination reduced net income slightly but was offset by other operational improvements.
• Inventory increases were noted due to higher silver and aluminum costs.